Assessing Novavax (NVAX) Valuation As Licensing Income And COVID Momentum Shape Expectations [Yahoo! Finance]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance
Novavax (NVAX) has been moving on the radar again, with shares showing a mix of shorter term pressure and stronger recent momentum that may have some investors reassessing the vaccine maker's risk and return profile. See our latest analysis for Novavax. At a share price of $9.62, Novavax has seen short term pressure with a 1 day share price return of a 1.23% decline and a 7 day share price return of a 4.56% decline, while its 90 day share price return of 41.47% and 1 year total shareholder return of 25.10% point to stronger recent momentum despite a 5 year total shareholder return of a 94.46% decline. If vaccine stocks are on your radar, this could be a handy moment to broaden your watchlist and check out 36 healthcare AI stocks With a US$1.6b market cap, US$1,123.48m in revenue, and an indicated 78% intrinsic discount, plus a 43% gap to analyst targets, you have to ask: is Novavax undervalued, or is the market already pricing in future growth? Most Popular Narrative: 30.2%
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- 2 Healthcare Stocks to Target This Week and 1 That Underwhelm [Yahoo! Finance]Yahoo! Finance
- 6 years since lockdown, here's a look at COVID vaccine guidance today [USA TODAY]USA TODAY
- Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock [Yahoo! Finance]Yahoo! Finance
- Novavax (NVAX) was upgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "sell (d+)" to "hold (c-)".MarketBeat
- Novavax (NVAX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..MarketBeat
NVAX
Earnings
- 2/26/26 - Beat
NVAX
Sec Filings
- 3/12/26 - Form 4
- 3/9/26 - Form 4
- 3/9/26 - Form 4/A
- NVAX's page on the SEC website